Changes in serum levels of SHBG, endogenous ligands and levonorgestrel induced by ethinylestradiol in NORPLANTR users

G. Noé, M. Pavez, H. B. Croxatto

Resultado de la investigación: Article

6 Citas (Scopus)

Resumen

This work was done in search for a model to examine target organ response to fluctuations in serum levels of sex hormone-binding globulin (SHBG) and its ligands. The time course and magnitude of fluctuations of SHBG, levonorgestrel (L-Ng), estradiol (E2), testosterone (T) and dihydrotestosterone (DHT) in serum were examined during and after treatment with 50 ug of ethinylestradiol (EE2) daily for 10 days in 10 volunteer women using NORPLANTR implants. Six of these volunteers were also treated with 20 ug of EE2 daily for 7 days and two additional volunteers using a copper-T IUD were treated with 50 ug of EE2 daily for 7 days. In all cases, SHBG and L-Ng levels increased in a close parallel manner several-fold above basal levels during treatment, reaching a maximum around two days after the last EE2 pill. In contrast, the levels of E2 and T increased in one subject, decreased in 5 and remained unchanged in 4, while changes of DHT were unrelated to those of the other ligands. Since the L-Ng "secretion rate" by NORPLANTR implants is constant, it follows that the effect of EE2 on its levels is due to a decreased metabolic clearance rate, most likely secondary to the increased binding of L-Ng to SHBG in serum. This interpretation is in agreement with the close parallelism in the fluctuations of L-Ng and SHBG.

Idioma originalEnglish
Páginas (desde-hasta)187-201
Número de páginas15
PublicaciónContraception
Volumen45
N.º3
DOI
EstadoPublished - 1 ene 1992

Huella dactilar

Levonorgestrel
Sex Hormone-Binding Globulin
Ethinyl Estradiol
Ligands
Volunteers
Serum
Dihydrotestosterone
Metabolic Clearance Rate
Testosterone
Copper
Estradiol
Therapeutics

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynaecology

Citar esto

@article{e177acade43047a99e626a55813eca8f,
title = "Changes in serum levels of SHBG, endogenous ligands and levonorgestrel induced by ethinylestradiol in NORPLANTR users",
abstract = "This work was done in search for a model to examine target organ response to fluctuations in serum levels of sex hormone-binding globulin (SHBG) and its ligands. The time course and magnitude of fluctuations of SHBG, levonorgestrel (L-Ng), estradiol (E2), testosterone (T) and dihydrotestosterone (DHT) in serum were examined during and after treatment with 50 ug of ethinylestradiol (EE2) daily for 10 days in 10 volunteer women using NORPLANTR implants. Six of these volunteers were also treated with 20 ug of EE2 daily for 7 days and two additional volunteers using a copper-T IUD were treated with 50 ug of EE2 daily for 7 days. In all cases, SHBG and L-Ng levels increased in a close parallel manner several-fold above basal levels during treatment, reaching a maximum around two days after the last EE2 pill. In contrast, the levels of E2 and T increased in one subject, decreased in 5 and remained unchanged in 4, while changes of DHT were unrelated to those of the other ligands. Since the L-Ng {"}secretion rate{"} by NORPLANTR implants is constant, it follows that the effect of EE2 on its levels is due to a decreased metabolic clearance rate, most likely secondary to the increased binding of L-Ng to SHBG in serum. This interpretation is in agreement with the close parallelism in the fluctuations of L-Ng and SHBG.",
author = "G. No{\'e} and M. Pavez and Croxatto, {H. B.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1016/0010-7824(92)90064-Z",
language = "English",
volume = "45",
pages = "187--201",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "3",

}

Changes in serum levels of SHBG, endogenous ligands and levonorgestrel induced by ethinylestradiol in NORPLANTR users. / Noé, G.; Pavez, M.; Croxatto, H. B.

En: Contraception, Vol. 45, N.º 3, 01.01.1992, p. 187-201.

Resultado de la investigación: Article

TY - JOUR

T1 - Changes in serum levels of SHBG, endogenous ligands and levonorgestrel induced by ethinylestradiol in NORPLANTR users

AU - Noé, G.

AU - Pavez, M.

AU - Croxatto, H. B.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - This work was done in search for a model to examine target organ response to fluctuations in serum levels of sex hormone-binding globulin (SHBG) and its ligands. The time course and magnitude of fluctuations of SHBG, levonorgestrel (L-Ng), estradiol (E2), testosterone (T) and dihydrotestosterone (DHT) in serum were examined during and after treatment with 50 ug of ethinylestradiol (EE2) daily for 10 days in 10 volunteer women using NORPLANTR implants. Six of these volunteers were also treated with 20 ug of EE2 daily for 7 days and two additional volunteers using a copper-T IUD were treated with 50 ug of EE2 daily for 7 days. In all cases, SHBG and L-Ng levels increased in a close parallel manner several-fold above basal levels during treatment, reaching a maximum around two days after the last EE2 pill. In contrast, the levels of E2 and T increased in one subject, decreased in 5 and remained unchanged in 4, while changes of DHT were unrelated to those of the other ligands. Since the L-Ng "secretion rate" by NORPLANTR implants is constant, it follows that the effect of EE2 on its levels is due to a decreased metabolic clearance rate, most likely secondary to the increased binding of L-Ng to SHBG in serum. This interpretation is in agreement with the close parallelism in the fluctuations of L-Ng and SHBG.

AB - This work was done in search for a model to examine target organ response to fluctuations in serum levels of sex hormone-binding globulin (SHBG) and its ligands. The time course and magnitude of fluctuations of SHBG, levonorgestrel (L-Ng), estradiol (E2), testosterone (T) and dihydrotestosterone (DHT) in serum were examined during and after treatment with 50 ug of ethinylestradiol (EE2) daily for 10 days in 10 volunteer women using NORPLANTR implants. Six of these volunteers were also treated with 20 ug of EE2 daily for 7 days and two additional volunteers using a copper-T IUD were treated with 50 ug of EE2 daily for 7 days. In all cases, SHBG and L-Ng levels increased in a close parallel manner several-fold above basal levels during treatment, reaching a maximum around two days after the last EE2 pill. In contrast, the levels of E2 and T increased in one subject, decreased in 5 and remained unchanged in 4, while changes of DHT were unrelated to those of the other ligands. Since the L-Ng "secretion rate" by NORPLANTR implants is constant, it follows that the effect of EE2 on its levels is due to a decreased metabolic clearance rate, most likely secondary to the increased binding of L-Ng to SHBG in serum. This interpretation is in agreement with the close parallelism in the fluctuations of L-Ng and SHBG.

UR - http://www.scopus.com/inward/record.url?scp=0026561838&partnerID=8YFLogxK

U2 - 10.1016/0010-7824(92)90064-Z

DO - 10.1016/0010-7824(92)90064-Z

M3 - Article

C2 - 1511607

AN - SCOPUS:0026561838

VL - 45

SP - 187

EP - 201

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 3

ER -